Running order
- Introduction to webinar: Tuula Nyman (10 min)
How this webinar came about, info about what the PCF offers
- Sandra Kyrk: Introduction to PEA technology (10 min)
- Marijana Rucevic: Oncology case study with Scientific affairs (20 mins)
Combined Mass Spectrometry and PEA based plasma proteomic approaches identify common and distinctive biomarkers for cancer immunotherapy
- Stefan Enroth PhD, Docent (Uppsala University, Sweden) (20 min)
High-precision biomarkers for Ovarian Cancer: Experiences with Olink Explore
- Q&A (15 min)
- Closing remarks (Sandra Kyrk) (5min)
What you will learn
Introduction to Proximity Extension Assay (PEA) technology for human proteomic analysis
Complement Mass Spectrometry based proteomic analysis to identify common and distinctive biomarkers for cancer immunotherapy
Proteomic approaches in plasma and serum samples to identify common and distinctive biomarkers
Identify high-precision biomarkers for Ovarian Cancer using Olink Explore
Registration is free of charge. More details can be found on the Olink registration page.
